Helicobacter pylori and Other Gastric Microbiota in Gastroduodenal Pathologies

Digestive Diseases

Volumn 34, Issue 3, 2016, Pages 210-216

  Schulz, Christian ^a   Schütte, Kerstin ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric microbiota; Helicobacter pylori; Microbiome; Microbiota

Indexed keywords

CARCINOGENESIS; DIET; DUODENUM DISEASE; ENVIRONMENTAL FACTOR; HELICOBACTER PYLORI; HUMAN; INTESTINE FLORA; MICROBIOME; MICROFLORA; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH DISEASE; DUODENUM; ENVIRONMENT; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; STOMACH;

DIET; DUODENUM; ENVIRONMENT; GASTROINTESTINAL MICROBIOME; HELICOBACTER PYLORI; HUMANS; STOMACH;

EID: 84971655065     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000443353     Document Type: Review

References (49)

1. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon ATR, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ: Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report. Gut 2012; 61: 646-664.
2. Malfertheiner P, Link A, Selgrad M: Helicobacter pylori: perspectives and time trends. Nat Rev Gastroenterol Hepatol 2014; 11: 628-638.
3. Menard A, Pere-Vedrenne C, Haesebrouck F, Flahou B: Gastric and enterohepatic helicobacters other than Helicobacter pylori. Helicobacter 2014; 19(suppl 1):59-67.
4. Correa P, Piazuelo MB: Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol Hepatol Rev 2011; 7: 59-64.
5. Correa P, Piazuelo MB: The gastric precancerous cascade. J Dig Dis 2012; 13: 2-9.
6. McColl KE, el-Omar E, Gillen D: Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 2000; 29: 687-703, viii.
7. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96(2 pt 2 suppl):615-625.
8. Lu H, Hsu PI, Graham DY, Yamaoka Y: Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128: 833-848.
9. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
10. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY: Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37: 2274-2279.
11. Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Boren T, Kodama T, Osato MS, Gutierrez O, Kim JG, Graham DY: Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol 2002; 40: 2244-2246.
12. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006; 55: 775-781.
13. Liu J, He C, Chen M, Wang Z, Xing C, Yuan Y: Association of presence/absence and on/ off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: A meta-analysis. BMC Infect Dis 2013; 13: 555.
14. Yamaoka Y: [Virulence factors of Helicobacter pylori: up-to-date]. Nihon Shokakibyo Gakkai zasshi 2010; 107: 1262-1272.
15. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M: Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol 2012; 13: 607-615.
16. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O: Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791.
17. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
18. Goh K, Chan WK, Shiota S, Yamaoka Y: Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16(suppl 1):1-9.
19. Sabria-Leal M, Pfaller MA, Morthland VH, Young SA, Hollis RJ, Werkmeister L, Kleiman-Wexler RL, Ephgrave KS: Molecular epidemiology of gastric colonization by Enterococcus faecalis in a surgical intensive care unit. Diagn Microbiol Infect Dis 1994; 19: 197-202.
20. Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T, McColl KE: Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 2000; 119: 339-347.
21. Sjostedt S, Heimdahl A, Kager L, Nord CE: Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. Eur J Clin Microbiol 1985; 4: 49-51.
22. Schulz C, Koch N, Schutte K, Pieper DH, Malfertheiner P: H. pylori and its modulation of gastrointestinal microbiota. J Dig Dis 2015; 16: 109-117.
23. Sharma BK, Santana IA, Wood EC, Walt RP, Pereira M, Noone P, Smith PL, Walters CL, Pounder RE: Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984; 289: 717-719.
24. Monstein HJ, Tiveljung A, Kraft CH, Borch K, Jonasson J: Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J Med Microbiol 2000; 49: 817-822.
25. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, Perez-Perez G, Blaser MJ, Relman DA: Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 2006; 103: 732-737.
26. Engstrand L, Lindberg M: Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 39-45.
27. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, Brodie EL, Dominguez-Bello MG: Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 2011; 5: 574-579.
28. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L: Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3: e2836.
29. Heimesaat MM, Fischer A, Plickert R, Wiedemann T, Loddenkemper C, Gobel UB, Bereswill S, Rieder G: Helicobacter pylori induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS One 2014; 9:e100362.
30. Vesper BJ, Jawdi A, Altman KW, Haines GK 3rd, Tao L, Radosevich JA: The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab 2009; 10: 84-89.
31. Tsuda A, Suda W, Morita H, Takanashi K, Takagi A, Koga Y, Hattori M: Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract. Clin Transl Gastroenterol 2015; 6:e89.
32. Sanduleanu S, Jonkers D, de Bruine A, Hameeteman W, Stockbrugger RW: Non-Helicobacter pylori bacterial flora during acidsuppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 2001; 15: 379-388.
33. Mattarelli P, Brandi G, Calabrese C, Fornari F, Prati GM, Biavati B, Sgorbati B: Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach. Microb Ecol Health Dis 2014: 25.
34. Yamaguchi N, Sonoyama K, Kikuchi H, Nagura T, Aritsuka T, Kawabata J: Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J Nutr 2005; 135: 109-115.
35. Sahasakul Y, Takemura N, Sonoyama K: Different impacts of purified and nonpurified diets on microbiota and toll-like receptors in the mouse stomach. Biosci Biotechnol Biochem 2012; 76: 1728-1732.
36. Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC, Wang HH, Abrams JA: Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: A crossover trial. Gastroenterology 2015; 149: 883-885. e9.
37. Bashir M, Prietl B, Tauschmann M, Mautner SI, Kump PK, Treiber G, Wurm P, Gorkiewicz G, Hogenauer C, Pieber TR: Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr 2015, Epub ahead of print.
38. Dethlefsen L, Relman DA: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108(suppl 1):4554-4561.
39. Perez-Cobas AE, Artacho A, Knecht H, Ferrus ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ: Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 2013; 8: e80201.
40. Savage DC: Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J Bacteriol 1969; 98: 1278-1283.
41. Mason KL, Erb Downward JR, Falkowski NR, Young VB, Kao JY, Huffnagle GB: Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun 2012; 80: 150-158.
42. Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, Wang TC, Fox JG: Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 2011; 140: 210-220.
43. Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG: Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut 2014; 63: 54-63.
44. Lin R, Zhou L, Zhang J, Wang B: Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int J Clin Exp Pathol 2015; 8: 5153-5160.
45. Giamarellos-Bourboulis E, Tang J, Pyleris E, Pistiki A, Barbatzas C, Brown J, Lee CC, Harkins TT, Kim G, Weitsman S, Barlow GM, Funari VA, Pimentel M: Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 2015; 50: 1076-1087.
46. Angelakis E, Armougom F, Carriere F, Bachar D, Laugier R, Lagier JC, Robert C, Michelle C, Henrissat B, Raoult D: A metagenomic investigation of the duodenal microbiota reveals links with obesity. PLoS One 2015; 10: e0137784.
47. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J: Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 2014; 4: 4202.
48. Gonzales CA, Fugueiredo C, et al: Helicobacter pylori cagA and vacA genotypes as predicotrs of progression of gastric preneoplastic lesions: A long term follow-up in a high-risk area in Spain. Am J Gastroenterol 2011; 106: 867-874.
49. Figueiredo C, Machado JC, et al: Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687.